Apodespan PR (carbidopa levodopa): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1564492295

Back Back to the list of medications

Medication indications

Apodespan PR 50/200 mg Prolonged-release Tablets

Idiopathic Parkinson's disease, in particular to shorten the off period in patients who have previously been treated with immediate-release levodopa/decarboxylase inhibitors, or with just levodopa who showed motor fluctuations.

Experience with Apodespan PR is limited in patients, who have not been previously treated with levodopa.


Route of administration: Oral
Molecule: carbidopa, levodopa

Patients' opinions on Apodespan PR

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

Fact sheet

Parkinson's disease

See the fact sheet